Delivery Order SPE2DB22D1106-SPE2DB25FFEN2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,980.16 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment (UDGM) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,580.02 to AmerisourceBergen Drug Corp for Erythromycin 0.5% Eye Ointment on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical supplier to federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Erythromycin 0.5% Eye Ointment. This firm fixed price delivery order, valued at $2,475.20, represents a non-set-aside competitive award and is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,960.32 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the company's Corporate Office...
- The Defense Logistics Agency awarded a $3,110.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% eye ointment on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Erythromycin 0.5% eye ointment in 3.5-gram units. This firm fixed-price delivery order, valued at $1,180.03, represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units, with a contract ceiling value of $1,460.44 and an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,301.90 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% eye ointment. The contract is firm fixed price with no set-aside designation and an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5 gram units. This contract, valued at $5,328.34, was competitively awarded without a set-aside designation and carries a firm fixed price structure. The award was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% eye ointment in 3.5-gram units, with a contract value of $1,362.97 and an ultimate completion date of July 30, 2025. This non-set-aside award reflects a competitive procurement process and represents a delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at approximately $1 billion through December...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFEN2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,499.80 to AmerisourceBergen Drug Corp for erythromycin 0.5% eye ointment, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen Drug Corp's larger pharmaceutical supply relationship with DLA. This award is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of medications, medical supplies, vaccines, and related healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated capability to meet federal procurement requirements through consistent competitive awards across multiple therapeutic domains and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/21/25 |